Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Debt Ratio (2021 - 2025)

Arcutis Biotherapeutics has reported Debt Ratio over the past 5 years, most recently at 0.25 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.25 for Q4 2025, down 18.1% from a year ago — trailing twelve months through Dec 2025 was 0.25 (down 18.1% YoY), and the annual figure for FY2025 was 0.25, down 18.1%.
  • Debt Ratio for Q4 2025 was 0.25 at Arcutis Biotherapeutics, down from 0.29 in the prior quarter.
  • Over the last five years, Debt Ratio for ARQT hit a ceiling of 0.69 in Q3 2023 and a floor of 0.18 in Q4 2021.
  • Median Debt Ratio over the past 5 years was 0.39 (2022), compared with a mean of 0.39.
  • Biggest five-year swings in Debt Ratio: skyrocketed 162.19% in 2023 and later crashed 48.02% in 2024.
  • Arcutis Biotherapeutics' Debt Ratio stood at 0.18 in 2021, then surged by 148.33% to 0.44 in 2022, then soared by 34.29% to 0.59 in 2023, then crashed by 48.02% to 0.31 in 2024, then dropped by 18.1% to 0.25 in 2025.
  • The last three reported values for Debt Ratio were 0.25 (Q4 2025), 0.29 (Q3 2025), and 0.31 (Q2 2025) per Business Quant data.